These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 1451955)

  • 21. Contraception and the risk of type 2 diabetes mellitus in Latina women with prior gestational diabetes mellitus.
    Kjos SL; Peters RK; Xiang A; Thomas D; Schaefer U; Buchanan TA
    JAMA; 1998 Aug; 280(6):533-8. PubMed ID: 9707143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased risk of inflammatory bowel disease associated with oral contraceptive use.
    Boyko EJ; Theis MK; Vaughan TL; Nicol-Blades B
    Am J Epidemiol; 1994 Aug; 140(3):268-78. PubMed ID: 8030630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke in users of low-dose oral contraceptives.
    Petitti DB; Sidney S; Bernstein A; Wolf S; Quesenberry C; Ziel HK
    N Engl J Med; 1996 Jul; 335(1):8-15. PubMed ID: 8637557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral contraceptives and diabetes mellitus.
    Hannaford PC; Kay CR
    BMJ; 1989 Nov; 299(6711):1315-6. PubMed ID: 2513935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospective study of exogenous hormones and risk of pulmonary embolism in women.
    Grodstein F; Stampfer MJ; Goldhaber SZ; Manson JE; Colditz GA; Speizer FE; Willett WC; Hennekens CH
    Lancet; 1996 Oct; 348(9033):983-7. PubMed ID: 8855854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exogenous sex hormones and the risk of rheumatoid arthritis.
    Hernandez-Avila M; Liang MH; Willett WC; Stampfer MJ; Colditz GA; Rosner B; Chang RW; Hennekens CH; Speizer FE
    Arthritis Rheum; 1990 Jul; 33(7):947-53. PubMed ID: 2369431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral contraceptive use and the risk of myocardial infarction.
    Rosenberg L; Palmer JR; Lesko SM; Shapiro S
    Am J Epidemiol; 1990 Jun; 131(6):1009-16. PubMed ID: 2343853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and metabolic considerations of long-term oral contraceptive use.
    Godsland IF; Crook D; Wynn V
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1955-63. PubMed ID: 1605285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study.
    Kjos SL; Shoupe D; Douyan S; Friedman RL; Bernstein GS; Mestman JH; Mishell DR
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1822-7. PubMed ID: 2256489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.
    Rosenberg MJ; Waugh MS
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):577-82. PubMed ID: 9757954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral contraceptives and breast cancer.
    Jick H; Walker AM; Watkins RN; D'Ewart DC; Hunter JR; Danford A; Madsen S; Dinan BJ; Rothman KJ
    Am J Epidemiol; 1980 Nov; 112(5):577-85. PubMed ID: 7435486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk.
    Harlow BL; Cramer DW; Geller J; Willett WC; Bell DA; Welch WR
    Am J Epidemiol; 1991 Sep; 134(5):445-53. PubMed ID: 1897499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective study of oral contraceptives and hypertension among women in the United States.
    Chasan-Taber L; Willett WC; Manson JE; Spiegelman D; Hunter DJ; Curhan G; Colditz GA; Stampfer MJ
    Circulation; 1996 Aug; 94(3):483-9. PubMed ID: 8759093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of smoking on prostacyclin formation and platelet aggregation in users of oral contraceptives.
    Roy S
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S364-8. PubMed ID: 10368522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral contraceptives and breast cancer in young women.
    Stadel BV; Rubin GL; Webster LA; Schlesselman JJ; Wingo PA
    Lancet; 1985 Nov; 2(8462):970-3. PubMed ID: 2865503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.